GlobeNewswire Inc.··Not SpecifiedT. Rowe Price CEO Joins Longeviti Board as Neurotech Firm Scales AI Brain Health Platform
T. Rowe Price CEO Robert W. Sharps joins Longeviti Neuro Solutions' board, bringing three decades of asset management expertise to support the AI-driven neurotechnology company's growth.
TROWartificial intelligencecorporate governance